This renewal application addresses the critical issue of treating metastatic cancer by combining three potent anti-cancer modalities: therapeutic ultrasound, chemotherapy and immune agonists. The enhanced accumulation (~25% ID/cc) and transport surrounding an ultrasonically-ablated region is shown to be far greater than that achieved with mild hyperthermia and is consistent across varied tumor biology. Further, the creation of small regions of ablation greatly enhances transport of tumor antigen into the draining lymph nodes and enhances systemic immune response. Through a collaboration with Image Guided Therapy, we have developed a flexible system to precisely control ultrasound therapy. Here, we will scale up our therapeutic ultrasound system from a 16-element annular array to a 256-element phased array for translation and develop the capability to model the thermal dose created by ultrasound. We will incorporate nonlinear modeling of propagation to predict lesion formation. Further, we will create protocols that combine ultrasound biological effects with chemotherapy and/or immune agonists in a systematic fashion. While cryoablation has been shown to be synergistic with immune agonists, ultrasound has far greater potential since insonation greatly improves drug delivery and transport;yet, this combination has yet to be explored. Our preliminary results and publications demonstrate the following: 1) by combining long circulating nanoparticles with ultrasound, we increase the fraction of therapeutic dose within primary tumors and the draining lymph nodes while decreasing systemic toxicity and avoiding leukopenia, 2) ultrasound ablation enhances the local CD8+ T cell population and dendritic and NK cell populations and 3) ultrasound combined with immune agonists increases local and systemic anticancer immunity, resulting in enhanced CD8+ T cell populations in treated and untreated tumors.
Our specific aims are to: scale up our technology in order to translate the resulting combination to larger animal models as the final step toward human translation;conduct studies of systemic nanoparticle chemotherapy combined with US to eliminate primary tumors in rodents and canines, and combine immunomodulatory agents with chemotherapeutics and ablation to create a systemic anticancer effect and treat metastatic cancer.

Public Health Relevance

We have demonstrated that ultrasound-enhanced delivery can be effective in treating primary cancers and here propose to extend these studies to larger animals using a scaled up therapeutic ultrasound system and to extend these studies to metastatic cancer by activation of the immune system.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA134659-05
Application #
8528136
Study Section
Special Emphasis Panel (ZRG1-SBIB-Q (03))
Program Officer
Farahani, Keyvan
Project Start
2008-07-01
Project End
2018-03-31
Budget Start
2013-05-15
Budget End
2014-03-31
Support Year
5
Fiscal Year
2013
Total Cost
$499,000
Indirect Cost
$170,958
Name
University of California Davis
Department
Biomedical Engineering
Type
Schools of Engineering
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Seo, Jai Woong; Baek, Hyounggee; Mahakian, Lisa M et al. (2014) (64)Cu-labeled LyP-1-dendrimer for PET-CT imaging of atherosclerotic plaque. Bioconjug Chem 25:231-9
Adamson, R H; Clark, J F; Radeva, M et al. (2014) Albumin modulates S1P delivery from red blood cells in perfused microvessels: mechanism of the protein effect. Am J Physiol Heart Circ Physiol 306:H1011-7
Dube, Nikhil; Seo, Jai W; Dong, He et al. (2014) Effect of alkyl length of peptide-polymer amphiphile on cargo encapsulation stability and pharmacokinetics of 3-helix micelles. Biomacromolecules 15:2963-70
Paoli, Eric E; Ingham, Elizabeth S; Zhang, Hua et al. (2014) Accumulation, internalization and therapeutic efficacy of neuropilin-1-targeted liposomes. J Control Release 178:108-17
Mahakian, Lisa M; Farwell, D Gregory; Zhang, Hua et al. (2014) Comparison of PET imaging with 64Cu-liposomes and 18F-FDG in the 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch model of oral dysplasia and squamous cell carcinoma. Mol Imaging Biol 16:284-92
Qin, Shengping; Fite, Brett Z; Gagnon, M Karen J et al. (2014) A physiological perspective on the use of imaging to assess the in vivo delivery of therapeutics. Ann Biomed Eng 42:280-98
Zhang, Guodong; Panigrahy, Dipak; Hwang, Sung Hee et al. (2014) Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis. Proc Natl Acad Sci U S A 111:11127-32
Chun-Yen Lai; Kruse, Dustin E; Ferrara, Katherine W et al. (2014) Creation and characterization of an ultrasound and CT phantom for noninvasive ultrasound thermometry calibration. IEEE Trans Biomed Eng 61:502-12
Thorsen, Frits; Fite, Brett; Mahakian, Lisa M et al. (2013) Multimodal imaging enables early detection and characterization of changes in tumor permeability of brain metastases. J Control Release 172:812-22
Zhang, Guodong; Panigrahy, Dipak; Mahakian, Lisa M et al. (2013) Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis. Proc Natl Acad Sci U S A 110:6530-5

Showing the most recent 10 out of 26 publications